Natriuretic Peptide Biomarkers as Information Indicators in Elderly Patients With Possible Heart Failure Followed Over Six Years: A Head-to-Head Comparison of Four Cardiac Natriuretic Peptides

Journal of Cardiac Failure

Volumn 13, Issue 6, 2007, Pages 452-461

  Alehagen, Urban ^a   Svensson, Erland ^b   Dahlström, Ulf ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

elderly patients; epidemiology; Heart failure; natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; N TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS;

EID: 34547485908     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.03.002     Document Type: Article

References (26)

1. Cowie M.R., Mosterd A., Wood D.A., Deckers J.W., Poole-Wilson P.A., Sutton G.C., et al. The epidemiology of heart failure. Eur Heart J 18 (1997) 208-225
2. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28 (1981) 89-94
3. Boomsma F., and van den Meiracker A.H. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 51 (2001) 442-449
4. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
5. Omland T., Aakvaag A., and Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76 (1996) 232-237
6. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
7. Wallen T., Landahl S., Hedner T., Saito Y., Masuda I., and Nakao K. Brain natriuretic peptide in an elderly population. J Intern Med 242 (1997) 307-311
8. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., and Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310 (2001) 193-197
9. Alehagen U., Eriksson H., Nylander E., and Dahlström U. Heart failure in the elderly. Characteristics of a Swedish primary health care population. Heart Drug 2 (2002) 211-220
10. Jensen-Urstad K., Bouvier F., Hojer J., Ruiz H., Hulting J., Samad B., et al. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol 81 (1998) 538-544
11. Karl J., Borgya A., Gallusser A., Huber E., Krueger K., Rollinger W., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177-181
12. Sundsfjord J.A., Thibault G., Larochelle P., and Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66 (1988) 605-610
13. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
14. Jöreskog K, Sörbom D. LISREL 8: structural equation modeling with the simplis command language. (Florence, KY): Lawrence Erlbaum Associates Inc; 1993.
15. Schiffrin S., Reynolds M., and Young F. Introduction to multi-dimensional scaling theory. Methods and applications (1981), Academic Press, New York
16. Hulsmann M., Berger R., Mortl D., Gore O., Meyer B., and Pacher R. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail 7 (2005) 552-556
17. Masson S., Latini R., Anand I.S., Vago T., Angelici L., Barlera S., et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52 (2006) 1528-1538
18. Alehagen U., Lindstedt G., Levin L.A., and Dahlstrom U. Risk of cardiovascular death in elderly patients with possible heart failure B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Int J Cardiol 100 (2005) 125-133
19. Schulz H., Langvik T.A., Lund Sagen E., Smith J., Ahmadi N., and Hall C. Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab Invest 61 (2001) 33-42
20. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
21. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., and Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults; effects of age and sex. Clin Chem Lab Med 40 (2002) 371-377
22. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Boomsma F., and van Veldhuisen D.J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail 7 (2005) 81-86
23. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B., and Hildebrandt P.R. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 3 (2001) 699-708
24. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
25. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
26. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50 (2004) 33-50